Holen Sie sich die Stockscreener-App
183.49
2.25%
-4.22
Handel nachbörslich:
183.49
Schlusskurs vom Vortag:
$187.71
Offen:
$188.12
24-Stunden-Volumen:
540.75K
Relative Volume:
0.45
Marktkapitalisierung:
$14.82B
Einnahmen:
$8.19B
Nettoeinkommen (Verlust:
$758.19M
KGV:
19.99
EPS:
9.18
Netto-Cashflow:
$1.06B
1W Leistung:
-5.36%
1M Leistung:
+10.91%
6M Leistung:
+28.64%
1J Leistung:
-38.07%
1-Tages-Spanne:
$181.09
$188.79
1-Wochen-Bereich:
$181.09
$194.40
52-Wochen-Spanne:
$125.10
$301.45
Icon Plc Stock (ICLR) Company Profile
Firmenname
Icon Plc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ICLR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
183.49 | 14.60B | 8.19B | 758.19M | 1.06B | 9.18 |
|
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-09 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-03 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2025-08-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-07-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-04-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-03-21 | Herabstufung | Goldman | Buy → Neutral |
| 2025-01-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-10-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Neutral |
| 2024-09-18 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2023-12-15 | Eingeleitet | Truist | Buy |
| 2023-09-13 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-17 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-01-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-11-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-09-07 | Eingeleitet | UBS | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-09-27 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-14 | Eingeleitet | Citigroup | Neutral |
| 2021-04-13 | Fortgesetzt | BofA Securities | Neutral |
| 2021-04-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Equal Weight |
| 2021-03-01 | Hochstufung | UBS | Neutral → Buy |
| 2021-02-26 | Hochstufung | Truist | Hold → Buy |
| 2020-07-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-04-20 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Hold |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-25 | Hochstufung | Mizuho | Neutral → Buy |
| 2018-10-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-09 | Eingeleitet | UBS | Sell |
| 2018-04-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2018-02-15 | Bestätigt | Mizuho | Neutral |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
| 2017-10-27 | Bestätigt | Barclays | Equal Weight |
| 2017-09-11 | Eingeleitet | BofA/Merrill | Buy |
| 2017-07-31 | Hochstufung | SunTrust | Hold → Buy |
| 2017-07-27 | Bestätigt | Mizuho | Neutral |
| 2017-06-29 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Icon Plc Aktie (ICLR) Neueste Nachrichten
Inspire Investing LLC Raises Holdings in Icon Plc $ICLR - MarketBeat
ICON plc (ICLR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
L. Roy Papp & Associates LLP Reduces Holdings in Icon Plc $ICLR - MarketBeat
Evercore Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $240 - 富途牛牛
ICON plc Experiences Valuation Adjustment Amidst Competitive Market Landscape - Markets Mojo
Running Oak Capital LLC Has $15.60 Million Holdings in Icon Plc $ICLR - MarketBeat
Sendero Wealth Management LLC Buys New Stake in Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Stock Position Increased by Marks Group Wealth Management Inc - MarketBeat
ICON plc Announces Third Quarter 2025 Earnings Call - MSN
AstraZeneca and Icon Plc Launch Eplontersen Safety Study for Pregnant and Lactating Individuals - TipRanks
What Analysts Are Saying About Icon Stock - Benzinga
ICON suspends COVID vaccine study after BARDA notice - MSN
Can ICON’s Rebound Sustain Momentum? - StocksToTrade
ICON plc Hits Day High with 7.67% Surge in Strong Intraday Performance - Markets Mojo
Real World Evidence Solutions Research and Forecast Report 2025-2030: Growth Opportunities in Emerging Markets and Increased Focus on End-To-End Rwe Services, & Personalized and Precision Medicine - GlobeNewswire Inc.
Is ICON plc’s Stock Soaring for the Right Reasons? - StocksToTrade
ICON plc Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
ICON plc (ICLR): Revolutionizing Clinical Trials with AI Innovations - MSN
ICON plc (ICLR) Stock Analysis: An Investor’s Guide to Understanding Its 31.67% Upside Potential - DirectorsTalk Interviews
ICON plc Schedules Third Quarter 2025 Earnings Conference Call - PharmiWeb.com
Canoe Financial LP Increases Position in Icon Plc $ICLR - MarketBeat
ICON Properties Plc (Malawi) | Interim Dividend Notice - AfricanFinancials
Farmers & Merchants Investments Inc. Purchases 2,181 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Sold by Swedbank AB - MarketBeat
Financiere des Professionnels Fonds d investissement inc. Purchases 11,894 Shares of Icon Plc $ICLR - MarketBeat
Goldman Sachs Group Inc. Sells 106,606 Shares of Icon Plc $ICLR - MarketBeat
Greenhaven Associates Inc. Takes Position in Icon Plc $ICLR - MarketBeat
LVM Capital Management Ltd. MI Sells 16,096 Shares of Icon Plc $ICLR - MarketBeat
U.S. Contract Research Organization Market Set for Dynamic Expansion as Key Players like IQVIA INC., ICON plc, Labcorp, Syneos Health - industrytoday.co.uk
Mizuho Securities Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $225 - 富途牛牛
Did ICON’s (ICLR) Internal CEO Succession Signal Strategic Continuity or Missed Opportunity for Change? - simplywall.st
Jefferies rates IQVIA, Charles River as Buy, ICON as Hold - MSN
Brokerages Set Icon Plc (NASDAQ:ICLR) PT at $219.64 - MarketBeat
Jefferies Downgrades ICON Public Limited (ICLR) to Hold From Buy - Insider Monkey
TD Cowen Maintains Icon PLC(ICLR.US) With Hold Rating, Cuts Target Price to $183 - 富途牛牛
Baird Financial Group Inc. Cuts Holdings in Icon Plc $ICLR - MarketBeat
ICON plc (ICLR): Assessing Valuation as CEO Transition Confirms Stability and 2025 Guidance - simplywall.st
Finanzdaten der Icon Plc-Aktie (ICLR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.17%
2.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):